Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

555
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
555
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

218
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
218

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of seizurogenic compounds in human and rat neurons in vitro: a multi-laboratory, multi-model assessment.

Neurotoxicology·2026
Same author

Protein Abundance of Hydrolytic Drug Metabolizing Enzymes in Different Tissues and across Species.

Journal of medicinal chemistry·2026
Same author

Drug transporters in drug disposition - highlights from the year 2025.

Drug metabolism reviews·2026
Same author

Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanism.

Toxicology and applied pharmacology·2026
Same author

IQ-MPS Affiliate perspectives on blood-brain barrier microphysiological systems: Progress and challenges ahead.

ALTEX·2026
Same author

A Thorough QT Study to Assess the Effects of Milvexian on Cardiac Repolarization in Healthy Participants.

Clinical pharmacology in drug development·2026

Related Experiment Video

Updated: Nov 20, 2025

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

2.0K

Cardiovascular microphysiological systems (CVMPS) for safety studies - a pharma perspective.

Amy Pointon1, Jonathan Maher2, Myrtle Davis3

  • 1Functional Mechanistic Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.

Lab on a Chip
|January 20, 2021
PubMed
Summary

Developing advanced cardiovascular microphysiological systems (CVMPS) integrates heart and vascular components for improved drug safety assessment. These complex models aim for more accurate predictions than current simplistic in vitro methods.

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.3K
A Cardiac Microphysiological System for Studying Ca2+ Propagation via Non-genetic Optical Stimulation
08:29

A Cardiac Microphysiological System for Studying Ca2+ Propagation via Non-genetic Optical Stimulation

Published on: March 21, 2025

1.1K

Related Experiment Videos

Last Updated: Nov 20, 2025

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

2.0K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.3K
A Cardiac Microphysiological System for Studying Ca2+ Propagation via Non-genetic Optical Stimulation
08:29

A Cardiac Microphysiological System for Studying Ca2+ Propagation via Non-genetic Optical Stimulation

Published on: March 21, 2025

1.1K

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Pharmacology

Background:

  • Cardiovascular system (CV) integrity is vital for systemic health.
  • Current in vitro models of heart and vasculature are simplistic and immature.
  • Existing models have limitations in predicting complex CV responses.

Purpose of the Study:

  • To develop more complex in vitro models of the cardiovascular system.
  • To integrate cardiac and vascular components into a functional microphysiological system (CVMPS).
  • To enhance risk assessment and mechanistic evaluation in pharmacological safety studies.

Main Methods:

  • Utilizing induced pluripotent stem-cell derived cardiomyocytes for cardiac components.
  • Employing endothelial and smooth muscle cells for vascular components.
  • Physically linking cardiac and vascular tissues to create integrated CVMPS.

Main Results:

  • Ongoing efforts focus on creating more mature and structurally complex CVMPS.
  • Initial successes involve simple bioengineered tissues coupled with fluidic systems.
  • Challenges include cell complexity, vascular realism, and component coupling.

Conclusions:

  • Integrated CVMPS offer a more holistic model for cardiovascular response.
  • Future adoption by pharmaceutical industry depends on efficiency and reproducibility.
  • Advanced CVMPS hold potential for improved drug safety and mechanistic understanding.